Title : Long-term maintenance of hemoglobin levels in hemodialysis patients treated with bi-weekly epoetin beta pegol switched from darbepoetin alfa: a single-center, 12-month observational study in Japan.

Pub. Date : 2019 Jun

PMID : 30426250






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Recent evidence on maintenance administration of epoetin beta pegol, a continuous erythropoiesis receptor activator (CERA), in dialysis patients shows the clinical benefit of bi-weekly administration (Q2W) in improving hematopoiesis and iron use efficiency. Iron erythropoietin Homo sapiens